TARAMELLI, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 8.455
EU - Europa 5.491
AS - Asia 2.988
SA - Sud America 376
AF - Africa 43
Continente sconosciuto - Info sul continente non disponibili 14
OC - Oceania 9
Totale 17.376
Nazione #
US - Stati Uniti d'America 8.331
IT - Italia 2.534
SG - Singapore 993
UA - Ucraina 797
CN - Cina 645
DE - Germania 604
SE - Svezia 434
VN - Vietnam 433
TR - Turchia 395
HK - Hong Kong 345
BR - Brasile 323
FI - Finlandia 256
IE - Irlanda 240
RU - Federazione Russa 167
GB - Regno Unito 164
FR - Francia 153
CA - Canada 80
IN - India 45
MX - Messico 32
BD - Bangladesh 28
JP - Giappone 27
ES - Italia 25
NL - Olanda 21
BE - Belgio 20
AR - Argentina 19
PL - Polonia 19
ZA - Sudafrica 18
IQ - Iraq 15
CZ - Repubblica Ceca 14
EU - Europa 13
AU - Australia 9
SA - Arabia Saudita 9
BG - Bulgaria 7
PK - Pakistan 7
PY - Paraguay 7
UZ - Uzbekistan 7
BO - Bolivia 6
LT - Lituania 6
NG - Nigeria 6
VE - Venezuela 6
AT - Austria 5
CO - Colombia 5
MD - Moldavia 5
CH - Svizzera 4
EC - Ecuador 4
KE - Kenya 4
MA - Marocco 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
DK - Danimarca 3
EG - Egitto 3
ID - Indonesia 3
JO - Giordania 3
KR - Corea 3
KZ - Kazakistan 3
LU - Lussemburgo 3
MN - Mongolia 3
NP - Nepal 3
PA - Panama 3
PH - Filippine 3
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
JM - Giamaica 2
LB - Libano 2
MY - Malesia 2
OM - Oman 2
PT - Portogallo 2
SV - El Salvador 2
TN - Tunisia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AO - Angola 1
BN - Brunei Darussalam 1
BW - Botswana 1
CI - Costa d'Avorio 1
CL - Cile 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GR - Grecia 1
HR - Croazia 1
IR - Iran 1
KG - Kirghizistan 1
MO - Macao, regione amministrativa speciale della Cina 1
NO - Norvegia 1
PE - Perù 1
RO - Romania 1
RS - Serbia 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TT - Trinidad e Tobago 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 17.376
Città #
Milan 1.657
Fairfield 860
Ashburn 664
Chandler 625
San Jose 625
Jacksonville 603
Singapore 542
Woodbridge 494
Houston 446
Seattle 358
Hong Kong 337
Wilmington 320
Ann Arbor 311
Cambridge 276
Nyköping 241
Dallas 239
Dublin 239
Dearborn 223
Princeton 214
Beijing 207
Como 196
Izmir 171
New York 151
Boardman 131
Rome 117
The Dalles 108
Dong Ket 104
Chicago 101
Lauterbourg 93
San Mateo 86
Los Angeles 83
Munich 67
San Diego 66
Ho Chi Minh City 63
Hanoi 56
Kocaeli 55
Toronto 51
Helsinki 50
Orem 46
Ogden 45
São Paulo 40
Santa Clara 33
Hefei 31
Guangzhou 29
Brooklyn 26
Frankfurt am Main 26
Tokyo 26
Buffalo 25
Casorezzo 25
Denver 24
Verona 24
London 23
Chennai 22
Council Bluffs 22
Nanjing 22
Turku 22
Washington 20
Brussels 19
Varese 19
Warsaw 19
Kunming 18
Montreal 18
Atlanta 17
Mexico City 17
Ponte Lambro 17
Stockholm 17
Düsseldorf 16
Manchester 16
San Francisco 16
Da Nang 15
Jinan 15
Shanghai 15
Phoenix 14
Poplar 14
Boston 13
Norwalk 12
Amsterdam 11
Johannesburg 11
Guarulhos 10
Dhaka 9
San Genesio Ed Uniti 9
Shenyang 9
Bulgorello 8
Nanchang 8
Zhengzhou 8
Belo Horizonte 7
Charlotte 7
Des Moines 7
Goiânia 7
Haiphong 7
Nuremberg 7
Olomouc 7
Rozzano 7
Salt Lake City 7
Sofia 7
Tashkent 7
Wuhan 7
Abuja 6
Ankara 6
Baghdad 6
Totale 12.253
Nome #
Loss of function of Ribonuclease T2, an ancient and phylogenetically conserved RNase, plays a crucial role in ovarian tumorigenesis 289
Characterization of RNASET2, the first human member of the Rh/T2/S family of glycoproteins 284
AIF-1 and RNASET2 Play Complementary Roles in the Innate Immune Response of Medicinal Leech 276
Human recombinant RNASET2-induced inflammatory response and connective tissue remodeling in the medicinal leech. 246
In silico prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6. 233
Pleiotropic modes of action in tumor cells of RNASET2, an evolutionary highly conserved extracellular RNase 230
Molecular signature induced by RNASET2, a tumor antagonizing gene, in ovarian cancer cells 228
A cell-autonomous oncosuppressive role of human RNASET2 affecting ECM-mediated oncogenic signaling 228
A 2-Mb YAC contig linking the plasminogen-apoprotein(a) gene family to the insulin-like growth factor 2 receptor (IGF2R) gene on the telomeric region of chromosome 6 (6q26-q27). 226
Characterization of multiple enhancer regions upstream of the apolipoprotein(a) gene. 226
Microenvironmental control of malignancy exerted by RNASET2, a widely conserved extracellular RNase. 225
Ten allelic apolipoprotein[a] 5' flanking fragments exhibit comparable promoter activities in HepG2 cells 224
Comparison of the baculovirus-insect cell and Pichia pastoris heterologous systems for the expression of the human tumor suppressor protein RNASET2 224
New strategies for expression and purification of recombinant human RNASET2 protein in Pichia pastoris 222
Cloning and characterization of a senescence inducing and class II tumor suppressor gene in ovarian carcinoma at chromosome region 6q27 214
T2 ribonuclease-mediated tumor suppression: an evolutionary conserved process involving a cross-talk between cancer cells and the immune system 206
Influence of metal ions on gene expression of BALB 3T3 fibroblasts 205
The human RNASET2 protein affects the polarization pattern of human macrophages in vitro 204
Naphthalene exposure: Effects on gene expression and proliferation in human cord blood cells 200
Intracellular trafficking of RNASET2, a novel component of P-bodies 200
A gene controlling fetal hemoglobin expression in adults is not linked to the non-alpha globin cluster 199
Nonsyndromic total anomalous venous return associated with a de novo translocation inolving chromosomes 10 and 21 t(10;21)(q23.1;q11.2) 195
A recombination event in the closely linked plasminogen and apolipoprotein(a)gene loci 195
Response of human cord blood cells to styrene exposure: evaluation of its effects on apoptosis and gene expression by genomic technology 194
The human genome project and the discovery of genetic determinants of cancer susceptibility 194
RNASET2 silencing affects miRNAs and target gene expression pattern in a human ovarian cancer cell model 194
Definition of the transcription initiation site of human plasminogengene in liver and non hepatic cell lines 193
Extracting Intercellular Signaling Network of Cancer Tissues using Ligand-Receptor Expression Patterns from Whole-tumor and Single-cell Transcriptomes 193
Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation. 191
New insights into hypoxia-related mechanisms involved in different microvascular patterns of bronchopulmonary carcinoids and poorly differentiated neuroendocrine carcinomas. Role of ribonuclease T2 (RNASET2) and HIF-1 α 187
Innate Immune Response Regulation by the Human RNASET2 Tumor Suppressor Gene 187
beta-Like globin RNA sequences in hemoglobin Lepore disease 186
Molecular cloning, tissue distribution, and chromosomal localization of the human homolog of the R2/Th/Stylar ribonuclease gene family 185
Molecular characterisation of the human apo(a)-plasminogen gene family clustered on the telomeric region of chromosome 6 (6q26-27). 184
Human NRD convertase: A highly conserved metalloendopeptidase expressed at specific sites during development and in adult tissues 179
Genetic and cytogenetic observations among different types of ovarian tumors are compatible with a progression model underlying ovarian tumorigenesis 178
Myocardial overexpression of ANKRD1 causes sinus venosus defects and progressive diastolic dysfunction 178
Mammalian Rh/T2/S-glycoprotein ribonuclease family genes:cloning of a human member located in a region of chromosome 6q27 frequently deleted in human malignancies 176
Human RNASET2 as a candidate stress-response gene involved in non-cell autonomous tumor suppression. 176
Human allantoicase gene: cDNA cloning, genomic organization and chromosome localization 174
Several liver specific DNAse hypersensitive sites are present in the intergenic region separating human plasminogen and apoprotein(A) genes 171
RNASET2 as a tumor antagonizing gene in a melanoma cancer model 171
Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return 170
Involvement of chromosome 6 in endometrial cancer 170
RNASET2 - An autoantigen in anaplastic large cell lymphoma identified by protein array analysis. 170
Xenopus allantoicase: Molecular cloning, enzymatic activity and developmental expression 169
Ribonuclease T2 (RNASET2) expression in the spectrum of neuroendocrine neoplasms of the lung. Relationships with hypoxia-related mechanisms and microvascular patterns 169
A large 6q deletion is a common cytogenetic alteration in fibroadenomas, pre-malignant lesions, and carcinomas of the breast 167
Tumor suppression by means of microenvironment-mediated stress response: the role of the human RNASET2 gene 166
Common fragile site FRA6E spans at least 7,5 Mb 165
The human RNASET2 tumor antagonizing gene as a novel stress-response gene potentially involved in microenvironment-mediated tumor suppression 165
Prediction and experimental validation of natural antisense transcripts in two cancer-associated regions of human chromosome 6 164
Early Involvement of 6q in Surface Epithelial Ovarian Tumors 164
BACE2 is stored in secretory granules of mouse and rat pancreatic beta cells 162
Transgenic mice expressing a human apolipoprotein[a] allele 161
Refinement of the LOH region 1 at 11q23.1 deleted in human breast carcinomas and sublocalization of 11 expressed sequence tags within the refined region 159
Motifs resembling hepatocyte nuclear factor 1 and activator protein 3 mediate the tissue specificity of the human plasminogen gene 158
Intracellular levels of the ANKRD1/CARP cardiac transcription repressor are regulated by the 26S proteasome 156
Human RNASET2 mediates tumor suppression by means of in vivo recruitment of stromal cells 156
Chromosome 6 abnormalities in ovarian surface epithelial tumors of borderline malignancy suggest a genetic continuum in the progression model of ovarian neoplasms 152
Mammalian Rh/T2/S-glycoprotein ribonucleasefamily genes: cloning of a human member located in a region of chromosome 6(6q27) frequently deleted in human malignancies 149
The pleiotropic roles of the human RNASET2 tumor suppressor gene 149
Molecular characterisation of human common fragile site FRA6E, a large genomic region spanning 9 Mb 148
Lecithin cholesterol acyl transferase deficiency: molecular analysis of a mutated allele 147
RNASET2 expression in ovarian epithelial tumors and clinico-pathological correlations. 145
Overexpression of Murine Rnaset2 in a Colon Syngeneic Mouse Carcinoma Model Leads to Rebalance of Intra-Tumor M1/M2 Macrophage Ratio, Activation of T Cells, Delayed Tumor Growth, and Rejection 145
Cloning a new human gene from chromosome 21q22.3 encoding aglutamic acid-rich protein expressed in heart and skeletal muscle 144
Are Tumor Suppressor Genes Playing a Role in the Deregulation of Tissue Organization in Cancer? 143
The oncosuppressive role of RNASET2 gene in a mouse tumor syngeneic model 143
Identification of putative cancer-related antisense transcripts in 6q21 and 6q27 142
The Human RNASET2 gene as a key component in the microenvironmental control of cancer growth 142
A TaqI polymorphism in a gene belongingto the human apoprotein(a)-plasminogen gene family on the telomeric region ofchromosome 6 (6q26-27) 139
A new constitutivelyactivating mutation of the Gs protein alpha subunit-gsp oncogene is found inhuman pituitary tumours 139
Tumor antagonizing genes and ovarian cancer: the role of the human RNASET2 gene. 139
Shortdirect repeats at the breakpoints of a novel large deletion in the CFTR genesuggest a likely slipped mispairing mechanism 135
Molecularcomparison of delta beta-thalassemia and hereditary persistence of fetalhemoglobin DNAs: evidence of a regulatory area? 134
Tumor and metastasis suppression by the human RNASET2 gene. 133
Ritorno Venoso polmonare Anomalo Totale: CARP, un possibile gene candidato 131
Functionalanalysis of the human lecithin cholesterol acyl transferase gene promoter. 131
Delta thalassemia: a non-deletion defect 130
RNASET2, a human tumor antagonizing gene supressing tumor growth in vivo but not in vitro 130
Genomic structure and organization of kringles type 3 to 10 of the apolipoprotein(a) gene in 6q26-27. 129
Organization of alpha-globin genes in Hb Hasharon(alpha 47 asp replaced by his) carriers 125
Extracting intercellular signalling network of cancer tissues using ligand-receptor expression patterns from whole-tumor and single cell transcriptomes. 124
A TaqI RFLP of the human plasminogen gene. 123
The homozygous state of G toA--117A gamma hereditary persistence of fetal hemoglobin. 123
Human RNASET2: A Highly Pleiotropic and Evolutionary Conserved Tumor Suppressor Gene Involved in the Control of Ovarian Cancer Pathogenesis 122
The in vivo tumor antagonizing role of human RNASET2 is mediated by host stromal cells recruitment 121
RNASET2 is a non-cell autonomous human tumor suppressor 119
Rnaset2, the first human ribonuclease of the rh/t2/s family, displays a role in tumor suppression 118
Molecular and functional characterization of a candidate gene for total anomalous pulmonary venous return 115
DNA sequences required forregulated expression of the human beta-globin gene. 107
Identification of the 5' end ofthe gene encoding a human insulin-responsive glucose transporter 106
Gamma delta beta-thalassaemias 1 and 2 are the result of a 100 kbp deletion inthe human beta-globin cluster 106
deltabeta-Thalassemia and HPFH. 105
Nucleotide sequence of thecDNA for lecithin-cholesterol acyl transferase (LCAT) from the rat. 103
Molecular and functional characterization of a candidate gene for Total Anomalous Pulmonary Venous return 102
Substitution of Leu for Pro-193in the insulin receptor in a patient with a genetic form of severe insulinresistance. 102
Sardinian G gamma-HPFH: aT----C substitution in a conserved "octamer" sequence in the G gamma-globinpromoter. 100
Prenatal diagnosis of hemoglobinopathies on the DNA of amniotic fluid fibroblasts 96
Totale 16.697
Categoria #
all - tutte 62.040
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 62.040


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021564 0 0 0 0 0 0 0 0 0 168 172 224
2021/20221.111 143 145 94 78 43 38 65 69 41 154 94 147
2022/20231.650 151 108 117 194 94 352 6 287 196 40 66 39
2023/20242.656 422 411 429 488 499 218 16 37 66 14 13 43
2024/20251.676 10 15 271 89 59 103 67 134 187 116 195 430
2025/20263.686 352 216 221 628 381 264 833 282 344 165 0 0
Totale 17.443